ECILC PEER ANALYSIS

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. — metric-by-metric comparison with peers and the industry median

ECILCEIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

🇹🇷 Turkey · IS · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ECILCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ECILC	PCRX	BHC	PAHC	AMPH	XERS	Ind. Median
P/E	—	203.75	—	14.71	11.50●	123.82	21.35
P/B	0.80	1.60	-0.87●	3.87	1.18	114.27	1.77
EV/EBITDA	33.84	10.61	4.05●	9.37	6.81	30.62	12.18
P/S	5.03	1.42	0.20●	0.93	1.26	4.72	2.08

Financial Health
Metric	ECILC	PCRX	BHC	PAHC	AMPH	XERS	Ind. Median
Current Ratio	1.73	4.73●	1.32	3.17	3.85	2.12	2.22
Debt/Equity	5.9%	62.9%	-1,010.0%●	217.6%	88.7%	286.9%	46.3%
NetDebt/EBITDA	-0.10	1.77	3.71	3.15	2.05	-1.61●	1.24

Profitability
Metric	ECILC	PCRX	BHC	PAHC	AMPH	XERS	Ind. Median
Net Margin	-3.6%	0.7%	-13.5%	6.3%	11.0%●	3.8%	4.0%
ROE	-0.6%	0.7%	—	30.3%●	10.4%	—	6.4%
ROA	-0.5%	0.4%	-4.7%	6.9%●	4.8%	3.4%	3.4%
EBITDA Margin	14.8%	16.1%	60.0%●	15.0%	26.6%	14.7%	18.2%

Growth + Dividend
Metric	ECILC	PCRX	BHC	PAHC	AMPH	XERS	Ind. Median
Rev. Growth	-2.3%	4.6%	-9.9%	26.0%	-1.1%	41.5%●	7.5%
NI Growth	—	—	—	199.6%●	-44.1%	—	5.0%
Div. Yield	2.6%●	—	0.0%	1.5%	—	—	2.0%
Payout	-365.1%	—	0.0%	20.4%	—	—	0.8%

Valuation
Metric	ECILC	GENIL	DEVA	Ind. Median
P/E	—	46.82	—	21.35
P/B	0.80	3.47	0.51●	1.77
EV/EBITDA	33.84	14.07	6.74●	12.18
P/S	5.03	1.86	0.70●	2.08

Financial Health
Metric	ECILC	GENIL	DEVA	Ind. Median
Current Ratio	1.73	1.33	2.00●	2.22
Debt/Equity	5.9%●	41.0%	23.1%	46.3%
NetDebt/EBITDA	-0.10●	1.10	0.89	1.24

Profitability
Metric	ECILC	GENIL	DEVA	Ind. Median
Net Margin	-3.6%	4.0%●	-4.4%	4.0%
ROE	-0.6%	8.7%●	-3.6%	6.4%
ROA	-0.5%	4.8%●	-2.5%	3.4%
EBITDA Margin	14.8%●	14.3%	12.0%	18.2%

Growth + Dividend
Metric	ECILC	GENIL	DEVA	Ind. Median
Rev. Growth	-2.3%	16.3%●	7.7%	7.5%
NI Growth	—	146.6%	—	5.0%
Div. Yield	2.6%●	0.0%	0.0%	2.0%
Payout	-365.1%	0.0%	0.0%	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ECILC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.